Accredited cases designed to support clinicians in applying data on HER2-targeted therapies to real-world NSCLC care. Test and refine your decision-making skills in these interactive scenarios, with video commentary from Enriqueta Felip and David Planchard.
This video-based case study will explore the current landscape of HER2-targeted approaches in NSCLC, including the role of ADCs and managing their associated treatment-related toxicities. Key clinical trial data on the efficacy and safety of HER2-directed therapies in patients with HER2 mutations or HER2 overexpression will be covered, delivering practical support for patient selection and treatment sequencing.
Duration: 15 minutes
This video-based case study will cover the prevalence, clinical impact, and management of brain metastases in HER2-positive NSCLC, including the limitations of traditional therapy and the safety and efficacy of HER2-targeted therapies in patients with brain metastases.
Duration: 15 minutes
